Skip to main content

Table 1 Demographic and anthropomorphic data

From: Lipid signatures of chronic pain in female adolescents with and without obesity

  Healthy Controls Pain/Healthy Weight Obese Alone Pain & Obese P-value
N 17 17 16 17  
Age (years) 14.8 [1.3] 15.5 [1.2] 14.7 [1.6] 15.1 [1.4] > 0.32
Race      0.23
White 15 16 12 11  
African-American 0 1 0 2  
Native American 0 0 0 1  
More than 1 2 0 4 3  
Hispanic      > 0.60
No 16 13 13 14  
Yes 1 3 3 3  
No answer 0 1 0 0  
BMI (percentile) 55 [41–70] 54 [38–73] 97 [95–98]* 98 [96–99]* < 0.001
Pain Location (n, %)      > 0.06
 Headache/Migraine   10 (58.8)   15 (88.2)  
 Extremities   3 (17.6)   0  
 Abdomen   1 (5.9)   2 (11.8)  
 Other   3 (17.6)   0 (0.0)  
Pain Duration (months)   24 [18–30]   24 [8–60] > 0.18
PFSD1 (days) 1.0 [0.0–2.0] 13.0 [5.5–14.0]** 1.0 [0.0–3.0] 7.0 [3.5–13.0]** < 0.001
PFSD4 (worst pain intensity)      < 0.001
  0.0 [0.0–5.0] 8.0 [7.0–9.5]** 0.0 [0.0–6.0] 8.0 [5.0–8.0]**  
  1. Data are shown as mean [SD] or median [25th–75th %] where appropriate
  2. BMI Body mass index, PFSD1 Pain Frequency Severity Duration Scale-1 (PFSD1; days with pain in the past 2 weeks), Pain Frequency Severity Duration Scale-4 (PFSD4; worst pain intensity in the past 2 weeks)
  3. *different from Healthy Controls and Pain/Healthy Weight groups (P < 0.001)
  4. **different from Healthy Controls and Obese Alone groups (P range, 0.003 to < 0.001)